Hims & Hers shares rally on results, but execs say GLP-1 drug shortage ‘is not abating’

Date:

Share post:




Shares of Hims & Hers Health Inc. rallied after hours on Monday after the wellness platform bumped its full-year sales forecast higher, as its efforts to offer more personalized care and more weight-loss drugs continue to draw subscribers.



Source link

Alexandra Williams
Alexandra Williams
Alexandra Williams is a writer and editor. Angeles. She writes about politics, art, and culture for LinkDaddy News.

Recent posts

Related articles

Super Micro needs a new CEO before its AI advantage erodes

Super Micro Computer Inc. was an early beneficiary of the artificial-intelligence boom. But with the server maker...

Why Constellation Energy’s stock is seeing a record selloff despite profit beat

Shares of Constellation Energy Corp. were in danger of a record selloff on Monday and were headed...

Harris and Trump command the market’s attention — but Jerome Powell may steal the spotlight

Investors are anxious about the possibility that it could take days, or even weeks, for the results...

What will OPEC+ decide on oil output? Here’s why it’s complicated.

Developments in the Middle East have and worries about the prospects for global demand have fueled volatile...

A weak jobs report couldn’t stop 10-year Treasury yields from rising

It took less than four hours for the impact of Friday’s weak nonfarm payrolls report for October...

October jobs report was a ‘head fake.’ Look at these numbers instead before Election Day.

A jobs report skewed by hurricanes and a strike at Boeing landed on voters’ radar with less...

Oil prices lifted by report Iran may be planning another major strike on Israel

Oil futures rose Friday, finding support after a news report said Iran may be planning a major...

Gold logs biggest drop since July, election may be a ‘pivot point’

Gold prices took an eye-catching hit on Thursday in posting their largest one-day decline since July —...